![Martin R. Brown](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martin R. Brown
Vorstandsvorsitzender bei Ambra Bioscience LLC
Profil
Martin R.
Brown is the founder of Ambra Bioscience LLC, which is founded in 2010, where he holds the title of Chief Executive Officer.
He previously worked as a Director of Information Systems at Eli Lilly & Co., Director at Equinox Center, Senior Vice President of Human Resources at Amylin Pharmaceuticals, Inc., and Media Contacts Relations, SVP-Finance & Operations at Elcelyx Therapeutics, Inc. Mr. Brown received his undergraduate degree and MBA from Drexel University.
Aktive Positionen von Martin R. Brown
Unternehmen | Position | Beginn |
---|---|---|
Ambra Bioscience LLC
![]() Ambra Bioscience LLC BiotechnologyHealth Technology Ambra Bioscience LLC operates as a research and development biotechnology company. It offers Lovidia a dietary supplement. The company was founded by Martin Brown and William Trebasky in March 2010 and is headquartered in San Diego, CA. | Vorstandsvorsitzender | 01.01.2010 |
Ehemalige bekannte Positionen von Martin R. Brown
Unternehmen | Position | Ende |
---|---|---|
ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Amylin Pharmaceuticals, Inc.
![]() Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Personalreferent | - |
Equinox Center | Direktor/Vorstandsmitglied | - |
Elcelyx Therapeutics, Inc.
![]() Elcelyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elcelyx Therapeutics, Inc. develops novel therapeutics based on gut sensory modulation. Its product NewMet is being developed for use by type 2 diabetes patients who have difficulty tolerating generic metformin or are contraindicated for its use. The firm also provides dietary supplements for weight management. The company was founded by Alain D. Baron in 2010 and is headquartered in San Diego, CA. | Finanzdirektor/CFO | - |
Ausbildung von Martin R. Brown
Drexel University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
Private Unternehmen | 4 |
---|---|
Elcelyx Therapeutics, Inc.
![]() Elcelyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elcelyx Therapeutics, Inc. develops novel therapeutics based on gut sensory modulation. Its product NewMet is being developed for use by type 2 diabetes patients who have difficulty tolerating generic metformin or are contraindicated for its use. The firm also provides dietary supplements for weight management. The company was founded by Alain D. Baron in 2010 and is headquartered in San Diego, CA. | Health Technology |
Amylin Pharmaceuticals, Inc.
![]() Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Equinox Center | |
Ambra Bioscience LLC
![]() Ambra Bioscience LLC BiotechnologyHealth Technology Ambra Bioscience LLC operates as a research and development biotechnology company. It offers Lovidia a dietary supplement. The company was founded by Martin Brown and William Trebasky in March 2010 and is headquartered in San Diego, CA. | Health Technology |